ADRB2 and cancer: The intracellular effects of Cas are mediated principally through non-bonded interactions with ADRB2, which results in metastasis in several cancer types, such as angiosarcoma, colorectal cancer, hemangioma, leukemia, lung, melanoma, nasopharyngeal, esophageal, ovarian, prostate, stomach and breast [4].